JP2008512395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512395A5 JP2008512395A5 JP2007530547A JP2007530547A JP2008512395A5 JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5 JP 2007530547 A JP2007530547 A JP 2007530547A JP 2007530547 A JP2007530547 A JP 2007530547A JP 2008512395 A5 JP2008512395 A5 JP 2008512395A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- aryl
- hydrogen
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004905182A AU2004905182A0 (en) | 2004-09-09 | Enzyme inhibitors and uses thereof | |
| AU2004905182 | 2004-09-09 | ||
| PCT/AU2005/001380 WO2006026832A1 (en) | 2004-09-09 | 2005-09-09 | Enzyme inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008512395A JP2008512395A (ja) | 2008-04-24 |
| JP2008512395A5 true JP2008512395A5 (https=) | 2008-10-23 |
| JP5031567B2 JP5031567B2 (ja) | 2012-09-19 |
Family
ID=36036029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530547A Expired - Fee Related JP5031567B2 (ja) | 2004-09-09 | 2005-09-09 | 酵素阻害剤およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080194636A1 (https=) |
| EP (1) | EP1789079B1 (https=) |
| JP (1) | JP5031567B2 (https=) |
| KR (1) | KR20070100878A (https=) |
| CN (1) | CN101039690A (https=) |
| CA (1) | CA2579768A1 (https=) |
| DK (1) | DK1789079T3 (https=) |
| ES (1) | ES2403340T3 (https=) |
| IL (1) | IL181819A (https=) |
| NZ (1) | NZ553688A (https=) |
| SG (1) | SG155901A1 (https=) |
| WO (1) | WO2006026832A1 (https=) |
| ZA (1) | ZA200702041B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2262797A4 (en) | 2007-11-19 | 2011-11-30 | Howard Florey Inst | INHIBITORS OF INSULIN REGULATED AMINO PEPTIDASE (IRAP) AND APPLICATIONS THEREOF |
| CN101284820B (zh) * | 2008-04-25 | 2011-05-04 | 南昌大学 | 一种氨肽酶抑制剂及合成方法 |
| CN103848805A (zh) * | 2012-12-06 | 2014-06-11 | 韩冰 | 一类治疗神经退行性疾病的化合物及其用途 |
| CN103896900A (zh) * | 2012-12-25 | 2014-07-02 | 韩冰 | 一类具有神经保护作用的化合物及其制备方法和用途 |
| WO2015182686A1 (ja) | 2014-05-28 | 2015-12-03 | アステラス製薬株式会社 | ピリジン誘導体 |
| AR102849A1 (es) | 2015-03-09 | 2017-03-29 | Astellas Pharma Inc | Compuesto de piridina bicíclica |
| JP2018527330A (ja) * | 2015-07-30 | 2018-09-20 | モナシュ ユニバーシティー | 線維症の処置 |
| WO2023099589A1 (en) | 2021-12-01 | 2023-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
| US5281619A (en) | 1992-09-25 | 1994-01-25 | Eli Lilly And Company | Therapy for diabetic complications |
| EP0599514A3 (en) * | 1992-11-18 | 1994-07-06 | Lilly Industries Ltd | Pyranoquinoline derivatives as inhibitors of cell proliferation. |
| US6680332B1 (en) * | 1999-06-04 | 2004-01-20 | Euro-Celtique S.A. | Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA |
| WO2002092594A1 (en) | 2001-05-16 | 2002-11-21 | Cytovia, Inc. | Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US20050020519A1 (en) * | 2001-08-02 | 2005-01-27 | Albiston Anthony L. | Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| US20030114418A1 (en) * | 2001-08-14 | 2003-06-19 | Pharmacia Corporation | Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor |
| ES2252656T3 (es) * | 2002-02-13 | 2006-05-16 | F. Hoffmann-La Roche Ag | Nuevos derivados de piridina y quinolina. |
| EP2262797A4 (en) * | 2007-11-19 | 2011-11-30 | Howard Florey Inst | INHIBITORS OF INSULIN REGULATED AMINO PEPTIDASE (IRAP) AND APPLICATIONS THEREOF |
-
2005
- 2005-09-09 ES ES05778990T patent/ES2403340T3/es not_active Expired - Lifetime
- 2005-09-09 CN CNA2005800353360A patent/CN101039690A/zh active Pending
- 2005-09-09 ZA ZA200702041A patent/ZA200702041B/xx unknown
- 2005-09-09 DK DK05778990.1T patent/DK1789079T3/da active
- 2005-09-09 JP JP2007530547A patent/JP5031567B2/ja not_active Expired - Fee Related
- 2005-09-09 NZ NZ553688A patent/NZ553688A/en not_active IP Right Cessation
- 2005-09-09 CA CA002579768A patent/CA2579768A1/en not_active Abandoned
- 2005-09-09 WO PCT/AU2005/001380 patent/WO2006026832A1/en not_active Ceased
- 2005-09-09 KR KR1020077008049A patent/KR20070100878A/ko not_active Withdrawn
- 2005-09-09 US US11/662,392 patent/US20080194636A1/en not_active Abandoned
- 2005-09-09 EP EP05778990A patent/EP1789079B1/en not_active Expired - Lifetime
- 2005-09-09 SG SG200905965-0A patent/SG155901A1/en unknown
-
2007
- 2007-03-08 IL IL181819A patent/IL181819A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10905701B2 (en) | Compositions and methods for inhibiting arginase activity | |
| US10676472B2 (en) | Crystal forms of glutaminase inhibitors | |
| US10793535B2 (en) | Heterocyclic glutaminase inhibitors | |
| CN107027291B (zh) | 用谷氨酰胺酶抑制剂的组合疗法 | |
| ES2243441T3 (es) | Derivados de imidazolio fundidos. | |
| US20160324829A1 (en) | Combination therapy with parp inhibitors | |
| AU2013344560A1 (en) | Heterocyclic glutaminase inhibitors | |
| JP2019504113A (ja) | 痛覚過敏を治療する方法 | |
| US20100266674A1 (en) | L-oddc prodrugs for cancer | |
| US20180055843A1 (en) | Combination therapy with glutaminase inhibitors | |
| US20160200697A1 (en) | Inhibition of wnt, tgf beta and hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders | |
| KR20120055692A (ko) | 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드 | |
| US20160129030A1 (en) | Treatment of mtor hyperactive related diseases and disorders | |
| US20130225647A1 (en) | Combination therapy with parp inhibitors | |
| TWI736519B (zh) | 治療神經退化性疾病之組合物及方法 | |
| JP2008512395A5 (https=) | ||
| JP2026506429A (ja) | Ｍｔａ協同的ｐｒｍｔ５阻害薬を使用した癌治療 | |
| US9205091B2 (en) | Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer | |
| JP2017515899A (ja) | カンナビノイド受容体メディエータとしてのピラゾール誘導体およびそれらの使用 | |
| AU2020402994A1 (en) | Methods of treating cancer | |
| JP2010511041A5 (https=) | ||
| US20070004777A1 (en) | Methods for treating or preventing acute myelogenous leukemia | |
| JP5830983B2 (ja) | 抗癌剤の副作用軽減剤 | |
| JP2010526073A (ja) | 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体 | |
| ES2898072T3 (es) | Métodos para tratar el cáncer de ovario |